Literature DB >> 16889827

Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue.

Erwin Rieder1, Anneliese Nigisch, Barbara Dekan, Marie-Theres Kasimir, Ferdinand Mühlbacher, Ernst Wolner, Paul Simon, Günter Weigel.   

Abstract

Supporting structures derived from biological tissue have been used in numerous tissue-engineering applications. This study focuses on the immune response of human leukocytes toward decellularized or glutaraldehyde (GA) cross-linked vascular tissue in vitro. Porcine and human pulmonary roots were sterilized with antibiotics, decellularized or cross-linked with GA. Proteins of the vascular tissue were extracted and the migratory response of human leukocytes toward protein extracts was examined using an in vitro migration chamber. Transmigrated leukocytes were counted and subsets (lymphocytes, monocytes, granulocytes) analyzed by flow cytometry. Decellularization significantly reduced the migration of monocytes compared to native porcine tissue. Although the proportion of transmigrating lymphocytes was much lower, decellularization again reduced the migratory response. Surprisingly, after decellularization granulocyte migration was still significantly higher than the negative control. Results comparable to those obtained with porcine material were found when human tissue was used for the experiments. Interestingly, migratory behavior toward extracts of GA-fixed porcine tissue was similar to that of decellularized specimens. We have shown that decellularization of vascular tissue reduces lymphocyte and monocyte recruitment comparable to cross-linking treatment. However, the migration of granulocytes, which are also known to be strongly involved in early inflammatory reactions, could be abolished neither by decellularization nor by fixation with GA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889827     DOI: 10.1016/j.biomaterials.2006.06.020

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  12 in total

1.  Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model.

Authors:  Jessica A DeQuach; Joy E Lin; Cynthia Cam; Diane Hu; Michael A Salvatore; Farah Sheikh; Karen L Christman
Journal:  Eur Cell Mater       Date:  2012-06-05       Impact factor: 3.942

2.  Novel utilization of serum in tissue decellularization.

Authors:  Liqiong Gui; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2010-04       Impact factor: 3.056

Review 3.  Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Tissue Eng Part B Rev       Date:  2019-11-27       Impact factor: 6.389

Review 4.  Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Authors:  Maelene L Wong; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

5.  Dose optimization of decellularized skeletal muscle extracellular matrix hydrogels for improving perfusion and subsequent validation in an aged hindlimb ischemia model.

Authors:  Melissa J Hernandez; Emma I Zelus; Martin T Spang; Rebecca L Braden; Karen L Christman
Journal:  Biomater Sci       Date:  2020-05-20       Impact factor: 6.843

Review 6.  Reclaiming a natural beauty: whole-organ engineering with natural extracellular materials.

Authors:  Samantha Traphagen; Pamela C Yelick
Journal:  Regen Med       Date:  2009-09       Impact factor: 3.806

7.  The consequence of biologic graft processing on blood interface biocompatibility and mechanics.

Authors:  Aurore B Van de Walle; Joseph S Uzarski; Peter S McFetridge
Journal:  Cardiovasc Eng Technol       Date:  2015-09       Impact factor: 2.495

8.  Development of decellularized human umbilical arteries as small-diameter vascular grafts.

Authors:  Liqiong Gui; Akihito Muto; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

9.  Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced via antigen removal achieve high in vivo patency rates.

Authors:  Manuela Lopera Higuita; Juan F Lopera Giraldo; Tiffany L Sarrafian; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2021-06-27       Impact factor: 10.633

10.  Genipin crosslinking reduced the immunogenicity of xenogeneic decellularized porcine whole-liver matrices through regulation of immune cell proliferation and polarization.

Authors:  Yujia Wang; Ji Bao; Xiujuan Wu; Qiong Wu; Yi Li; Yongjie Zhou; Li Li; Hong Bu
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.